DOJ officials say the drug wholesaler could face “billions of dollars” in penalties for failing to report diversion of prescription opioid pain medications shipped to pharmacies across the U.S.
DOJ officials say the drug wholesaler could face “billions of dollars” in penalties for failing to report diversion of prescription opioid pain medications shipped to pharmacies across the U.S.